Jan 19,2022 02:33 PM
Ind-Ra continues to take a consolidated view of Cipla and its subsidiaries.
Cipla allots 20,736 equity shares under ESOP Jan 15,2022
|Resolution Type||Description Of Resolution||IiAS Recommendation|
|Name||LTP||PE||Mar Cap||NP Qtr||Div. Yld||Sales Qtr||BV|
|Sun Pharmaceuticals Industries Ltd||808.75||108.74||194,118.20||809.07||0.93||4,120.93||113.47|
|Divis Laboratories Ltd||4,179.40||52.64||110,935.34||606.39||0.48||1,967.86||372.89|
|Dr Reddys Laboratories Ltd||4,496.15||46.28||74,862.73||449.00||0.56||3,809.50||1,049.62|
|Piramal Enterprises Ltd||2,527.85||235.51||60,310.32||34.34||1.23||515.35||962.90|
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Cipla Ltd is one of the leading pharmaceutical companies in India. The company focuses on development of new formulations and has a wide range of pharmaceutical products. The product portfolio includes over 1,500 products across wide range of therapeutic categories.Cipla Ltd was incorporated in the year 1935 with the name Chemical, Industrial & Pharmaceutical Laboratories Ltd. Khwaja Abdul Hamied, the founder of Cipla gave the company ... More
Jan 21, 2022 08:02 PM
The company’s consolidated revenue in the period stood at Rs4,011.9cr, down 1.73% yoy but up 1.85% qoq.
26 Oct 2021
01 Oct 2021
Quarterly ResultsPlease find enclosed letter dated 26 October 2021(As per BSE Announcement Dated on ... More
25 Aug 2021
27 Jul 2021
Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, ... More
14 May 2021
09 Aug 2021
Cipla Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 14,... More
Verify your OTP
Didn't receive the OTP yet? Resend